Whipkey v. Aqua-Chem, Inc.
2012 Ohio 918
Ohio Ct. App.2012Background
- Plaintiff-appellant Marilyn Whipkey, as Personal Representative of William Whipkey, appeals a dismissal order in an asbestos case.
- The Whipkeys filed suit in 2004 seeking damages for William’s lung cancer allegedly caused by asbestos exposure.
- After HB 292 became effective, defendants moved to dismiss for lack of prima facie evidence under the new statute.
- The trial court initially allowed the case to proceed, then the issue was appealed up to the Ohio Supreme Court, which remanded.
- On remand, Ford moved to administratively dismiss for failure to submit prima facie evidence under HB 292, which the trial court granted.
- The court ultimately held HB 292 cannot penalize a nontraditional patient and reversed the dismissal, remanding for further proceedings.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether HB 292 retroactively applies to pre-existing asbestos claims. | Whipkey argues retroactive application is permissible and not punitive. | Defendants contend HB 292 applies retroactively and requires prima facie evidence. | Yes; HB 292 applies retroactively to pre-existing claims. |
| Whether the medical evidence submitted meets R.C. 2307.92(C) prima facie requirements. | Whipkey asserts the doctors’ reports establish substantial factor causation. | Defendants argue the reports lack a doctor-patient relationship and fail prima facie tests. | The evidence suffices to establish prima facie causation under Sinnott. |
Key Cases Cited
- Sinnott v. Aqua-Chem, Inc., 116 Ohio St.3d 158 (2007-Ohio-5584) (doctor-patient relationship not strict; substantial evidence can meet prima facie)
- Ackison v. Anchor Packing Co., 120 Ohio St.3d 228 (2008-Ohio-5243) (retroactivity of HB 292 purposefully addressed asbestos claims)
- Bland v. Ajax Magnethermic Corp., 2011-Ohio-1247 (2011-Ohio-1247) (distinguishable; Sinnott controls retroactivity analysis)
- Hoover v. Norfolk S. Ry. Co., 2010-Ohio-2984 (2010-Ohio-2984) (de novo review of medical evidence to establish prima facie)
